BGI Genomics Co Ltd. Stock Analysis 300676.SZ

BGI Genomics Co., Ltd. is a holding company that engages in development of science and technology services in genomics field. The company is headquartered in Shenzhen, Guangdong and currently employs 3,580 full-time employees. The company went IPO on 2017-07-14. The firm's main business is to provide research services and comprehensive solutions for precision medicine testing for scientific research institutions, enterprises, institutions, medical institutions, social health organizations and others through multi-omics big data technology means such as genetic testing, mass spectrometry testing, and bioinformatics analysis. The firm mainly provides basic research and clinical application services for reproductive health, tumor and chronic disease prevention and control and translational medicine services, basic research and clinical application services for infection prevention and control, multi-omics big data services and synthesis business, and comprehensive solutions for precision medicine testing